This article is part of the Thematic Series \"Synthesis in the glycosciences II\".

Introduction
============

The triterpene saponin glycyrrhizin (**GL**) and its aglycon glycyrrhetinic acid (**GA**) are the main triterpene components of licorice roots and harbor various pharmacological activities, including antitumor, anti-inflammatory, antioxidant and antiviral properties \[[@R1]--[@R2]\]. The antiviral activities have been reported to be directed against a broad spectrum of viruses comprising herpes-, corona-, alpha-, and flaviviruses, HIV, Epstein--Barr virus, influenza A virus (IAV), vaccinia and polio type I viruses as examples \[[@R3]--[@R8]\]. In particular anti-influenza virus activities have been described, although the underlying mechanisms of action are diverse \[[@R9]--[@R12]\]. In order to evaluate the potential antiviral properties of glycyrrhizin derivatives, we set out to modify the chemical environment in the vicinity of ring A of glycyrrhetinic acid. The envisaged modifications should assess the impact of acidic groups, which reside at the glucuronic acid residues in the β-(1→2)-linked disaccharide unit of **GL**, with respect to antiviral properties ([Fig. 1](#F1){ref-type="fig"}).

![Structure of glycyrrhizin (**GL**), carbenoxolone (**CBX**), and spacer analogues.](Beilstein_J_Org_Chem-08-705-g002){#F1}

Previously, ring A modified derivatives of glycyrrhetinic acid were prepared containing 3-amino, 3-thio and 1-thio groups, allowing for an extension of the oleanolic acid unit with spacer groups as well as facile covalent attachment of carboxyalkyl groups by alkylation or acylation reactions \[[@R13]--[@R14]\]. For the compounds included in this investigation, the size of the spacer group was selected to closely match the formal distances between the A-ring and the carboxylic acid function present in the glucopyranosiduronic residues of the parent compound glycyrrhizin (**GL**) and in the hemisuccinate moiety of the glycyrrhetinic acid derivative carbenoxolone (**CBX**) \[[@R15]\] ([Fig. 1](#F1){ref-type="fig"}). For the sake of clarity, the nomenclature and numbering for the triterpene system as used throughout this report is illustrated in [Fig. 1](#F1){ref-type="fig"}. In order to enhance resistance against enzymatic cleavage by glucuronidases, the glucuronic acid residue was introduced through a stable thioglycosidic linkage.

Results and Discussion
======================

Synthesis of 3-amino derivatives
--------------------------------

Commercially available methyl (2,3,4-tri-*O*-acetyl-D-glucopyranosyl)uronate bromide (**1**) was first reacted with potassium thioacetate in DMF to furnish the known 1-thioacetyl derivative **2** in 82% yield \[[@R16]\]. Subsequent treatment of **2** with sodium methoxide, under controlled conditions at low temperature (−60 °C → −45 °C), provided the corresponding glucuronyl 1-thiol **3** in 89% yield \[[@R17]--[@R18]\]. Reaction of **3** with an excess of 1,2-dibromoethane (3--4 equiv) in DMF in the presence of sodium hydride, with the strict exclusion of oxygen, afforded the 2-bromoethyl 1-thioglycoside **4** in 80% yield. Under these conditions formation of the bis-substitution product **5** (3%) and the disulfide oxidation product of 1-thiol **3** was observed in only very minor quanities. The corresponding 2-iodoethyl derivative **6** was prepared by a Finkelstein reaction from the bromoethyl 1-thioglycoside **4** in 95% yield ([Scheme 1](#C1){ref-type="fig"}).

![Synthesis of methyl 2-haloethyl 1-thio-glucuronide derivatives: (a) 1 M NaOMe, MeOH, −60 °C to −45 °C, 89% ; (b) Br(CH~2~)~2~Br, NaH, DMF, −5 °C (80% for **4**, 3% for **5**); (c) NaI, acetone, 4 °C, 16 h, 95%.](Beilstein_J_Org_Chem-08-705-g004){#C1}

The previously reported 3β-amino derivative of the diphenylmethyl ester of glycyrrhetinic acid **7** \[[@R19]\] was then used for the introduction of the spacer-extended 1-thio-glucopyranosiduronate residue. Coupling of the 3β-amino derivative **7** with two equivalents of the 2-iodoethyl glycoside **6** in DMF in the presence of Hünig base proceeded smoothly to provide the alkylated amine **8** in 79% yield without the formation of a bis-alkylated product ([Scheme 2](#C2){ref-type="fig"}), whereas the use of the corresponding bromide **4** resulted in a significantly slower reaction. At elevated temperature, elimination leading to the corresponding hexenuronic acid derivative was observed (structure not shown). The secondary amino group in compound **8** was subjected to further derivatization by N-acetylation (triethylamine, acetic anhydride), which gave compound **9** in 96% yield. Deprotection of the ethyl 1-thio-glucuronide derivatives **8** and **9** was achieved by acid-catalyzed cleavage of the diphenylmethyl ester group with TFA/anisole (as carbocation scavenger), giving the monoacid derivatives **10** and **11** in 75% and 89% yield, respectively. Subsequent transesterification of **10** and **11** with methanolic NaOMe afforded the deacetylated methyl ester glucuronide derivatives **12** and **14**, respectively, which were finally fully deprotected by hydrolysis of the methyl ester group with 0.2 M methanolic NaOH to furnish the diacid derivatives **13** and **15**, in high overall yield.

![Synthesis of thioalkylglucuronide **GA** derivatives: (a) DMF, DIPEA, 45--50 °C, 16 h, 79%; (b) TEA, Ac~2~O, DCM, 0 °C, 2 h, 96%; (c) anisole, TFA, DCM, rt, 3 h (75% for **10**, 89% for **11**); (d) 0.1 M NaOMe, MeOH, 0 °C (89% for **12**, 97% for **14**, 99% for **18**); (e) 0.2 M NaOH, MeOH, rt, 3 h (91% for **13**, \~quant. for **15**, 99% for **19**); (f) MeO~2~C(CH~2~)~2~COCl in DCM, DIPEA, 0 °C to rt, 90 min, then anisole, TFA, DCM, 0 °C, 3 h, 83% for two steps.](Beilstein_J_Org_Chem-08-705-g005){#C2}

A second series of compounds was designed as glucuronide-extended amide derivatives of the previously reported carbenoxolone analogue **16** \[[@R20]--[@R21]\]. Reaction of the 3-amino group of **8** with the monomethyl ester of succinic acid chloride in dichloromethane in the presence of Hünig base was followed by deblocking of the diphenylmethyl ester group to afford **17** in a combined yield of 83%. The acetyl groups of **17** were removed under Zemplén conditions to afford the dimethyl ester **18**. Alkaline hydrolysis of the ester groups eventually gave the triacid derivative **19** in good yield. In contrast to the straightforward chemical transformations, analysis of the NMR spectra of this series of compounds was challenging and the N-acylated derivatives **9**, **11**, **14**, **15** and **17**--**19** revealed complex spectra. Whereas the secondary amides of 3β-amino-glycyrrhetinic acid derivatives displayed coherent NMR signals \[[@R22]--[@R23]\], the tertiary amides frequently exist as mixtures of *cis*/*trans* rotamers leading to the duplication of signals \[[@R24]--[@R25]\]. The steric congestion at position 3 exerted by the two adjacent methyl groups may additionally contribute to the restricted rotation of the amide linkage. Thus, in the ^1^H NMR spectra of the *N*-acetyl- and *N*-succinyl derivatives, recorded at room temperature, two sets of signals in an approximate 6:4 ratio were observed. Reversible coalescence of these signal groups was observed upon heating a solution of the *N*-acetyl derivative **11** up to 100 °C in DMSO-*d* ~6~ and subsequent cooling to room temperature ([Fig. 2](#F2){ref-type="fig"}), supporting the assignment of two signal data sets for two rotamers. The orientation of the amide carbonyl group in the rotamers also had a pronounced effect on the NMR chemical shifts of carbon and proton signals in ring A, which led to a shift of H-3 to lower field (δ 4.47) and to a shielding of C-3 (δ 59.9) for the minor isomer, whereas the inverse effects were seen for the major rotamer (δ for H-3 at 3.36 and δ for C-3 at 66.7). Similar, but less-pronounced effects were observed for the respective ^1^H and ^13^C signals at position 5 of ring A (see [Supporting Information File 1](#SD1){ref-type="supplementary-material"}).

![400 MHz ^1^H NMR expansion plots of the carbohydrate region of compound **11**, recorded at various temperatures.](Beilstein_J_Org_Chem-08-705-g003){#F2}

Synthesis of 3-thio derivatives
-------------------------------

Complementing the series of the 3β-amino series, related 3-thio derivatives were employed for the spacer elongation \[[@R14]\]. The previously reported 1,2-dehydro-3-thiol derivative **20** was subjected to alkylation with the 2-iodoethyl 1-thioglucuronide compound **6** in the presence of K~2~CO~3~ to furnish the thioether-bridged glucuronide triterpene **21** in 60% yield. Deprotection of **21** was performed in two steps as described for **10**, which furnished the methyl ester derivative **22** and the glucuronic acid compound **23**, respectively, in good yields ([Scheme 3](#C3){ref-type="fig"}).

![Synthesis of 3-thioether-bridged glucuronide derivatives: (a) K~2~CO~3~, acetone, 60%; (b) 0.8 M NaOMe, MeOH, 71%; (c) 0.2 M NaOH, MeOH, 95% .](Beilstein_J_Org_Chem-08-705-g006){#C3}

Antiviral activities
--------------------

For biological testing the compounds were dissolved in DMSO and diluted in cell culture medium to a maximum final DMSO concentration of 1%. For determination of the cytotoxicity of the compounds, MDCK cells were treated with compound concentrations ranging from 3.1 µM to 250 µM for 48 h and then cell viability was determined as a surrogate endpoint for cytotoxicity. Except for the aglycons of **GL**, namely glycyrrhetinic acid (**GA**) and the hemisuccinate carbenoxolone (**CBX**), which showed CC~50~ values (half-maximal cytotoxic concentration) of 7.4 µM and 17.8 µM, respectively, none of the compounds tested were toxic at concentrations up to 250 µM. **GL** was not toxic at 2500 µM ([Table 1](#T1){ref-type="table"}). The antiviral activity of the compounds was determined by infecting MDCK cells with influenza A H3N2 virus and treating them with different concentrations of compounds at the same time. Most compounds prevented virus-induced cytopathicity and restored cell viability compared to virus-infected control cells. The antiviral activity of glycyrrhizin (**GL**) against influenza and other viruses reported in the literature was confirmed in this study resulting in an IC~50~ of 1026 µM ([Table 1](#T1){ref-type="table"}). **GA** and **CBX** did not show any antiviral activity at nontoxic concentrations. Compounds **12**, **13**, **14**, **15**, **18** and **19**, which possess a (1-thio-β-D-glucopyranosyluronic acid)ethylamino substituent at position 3 of **GA** did not show toxicity at concentrations up to 250 µM, but showed enhanced antiviral activity compared to **GL**. Good activities were found for compounds **12** and **18** with IC~50~ values of 220.4 μM and 125 µM, respectively, being between 4.7-fold to 8-fold more active compared to the lead compound **GL**. The methyl ester **14** containing the N-acetylated spacer group was approximately 14-fold more active compared to **GL**, reflected by an IC~50~ value of 72.1 µM. The free acid **15** displayed an IC~50~ value in the same range as the methyl ester **14**. Replacement of the *N*-acetyl group of **14** with a methylsuccinyl group (**18**) did not improve the activity; however, the compound was still active with an IC~50~ value of 125 µM. The cleavage of both methyl ester groups of this compound resulted in compound **19** and led to the loss of antiviral activity up to the highest concentration tested (250 µM). Compound **16** containing only the *N*-succinyl substituent is a close analogue to **CBX** bearing an amide instead of the ester group. Unlike **CBX**, which is toxic at low concentrations, **16** was not toxic but inactive, indicating that the glucuronic acid moiety is associated with the antiviral properties. This was further supported by the data obtained with compound **23** containing a 1-thioethyl-linked glucuronic acid residue at position 3 of 1,2-dehydro-glycyrrhetinic acid. Compound **23** showed good activity with an even lower IC~50~ value of 54 µM compared to **15**, and exhibited also no cytotoxicity at the concentrations tested.

###### 

Cytotoxic concentration 50% (CC~50~) of compound-treated uninfected cells and antiviral activities, shown as half-maximal inhibitory concentration (IC~50~) values of glycyrrhizin (**GL**) analogues.

  ---------- ------------------------------------------- --------------- ----------------
  Compound   Substructure                                CC~50~ \[µM\]   IC~50~ \[µM\]
                                                                         
  **GL**     ![](Beilstein_J_Org_Chem-08-705-i001.jpg)   \>2500          1026 ± 181
  **GA**     ![](Beilstein_J_Org_Chem-08-705-i002.jpg)   7.4 ± 0.05      nd^a^
  **CBX**    ![](Beilstein_J_Org_Chem-08-705-i003.jpg)   17.8 ± 2.3      nd^a^
  **12**     ![](Beilstein_J_Org_Chem-08-705-i004.jpg)   \>250           220.4 ± 41
  **13**     ![](Beilstein_J_Org_Chem-08-705-i005.jpg)   \>250           nd (\>250)^b^
  **14**     ![](Beilstein_J_Org_Chem-08-705-i006.jpg)   \>75            72.1 ± 19.1^c^
  **15**     ![](Beilstein_J_Org_Chem-08-705-i007.jpg)   \>250           87 ± 7.9
  **16**     ![](Beilstein_J_Org_Chem-08-705-i008.jpg)   \>250           nd (\>250)^b^
  **18**     ![](Beilstein_J_Org_Chem-08-705-i009.jpg)   \>250           125 ± 15.9
  **19**     ![](Beilstein_J_Org_Chem-08-705-i010.jpg)   \>250           nd (\>250)^b^
  **23**     ![](Beilstein_J_Org_Chem-08-705-i011.jpg)   \>250           54 ± 13
  ---------- ------------------------------------------- --------------- ----------------

^a^nd not determined due to cytotoxicity; ^b^nd (\>250) no detectable antiviral activity up to 250 µM; ^c^approximate value, since the compound precipitates at concentrations \>75 μM.

Conclusion
==========

3-Amino and 3-thio derivatives of glycyrrhetinic acid served as versatile scaffolds for the attachment of glycosyl extensions through high-yielding alkylation reactions. The glucuronide derivatives linked via a thioethyl spacer group to the oleanolic acid unit exhibited no toxicity at concentrations up to 250 μM and significantly enhanced the anti-influenza virus activity of the natural triterpene glycoside glycyrrhizin.

Supporting Information
======================

###### 

Experimental details for the preparation of compounds **2**--**19** and **21**--**23** as well as the biological assays.
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